Ireland - English - HPRA (Health Products Regulatory Authority)

fresenius kabi limited - adenosine - solution for injection - 3 mg/ml - other cardiac preparations

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - adenosine, quantity: 6 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - therapeutic indications: adenosine viatris is indicated for the rapid conversion to a normal sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (wolff-parkinson-white syndrome). diagnostic indications: adenosine viatris is indicated as an aid to diagnosis of broad or narrow qrs complex supraventricular tachycardias. although adenosine viatris is not effective in converting atrial flutter, atrial fibrillation or ventricular tachycardia to sinus rhythm, the slowing of av conduction helps diagnosis of atrial activity. in this respect adenosine should be used as an adjunct to, but not a replacement for, clinical and ecg observations. it should be used only when, despite all diagnostic attempts, doubt still persists. adenosine viatris can also be used for improved diagnostic sensitivity of intracavity electrophysiological investigations.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - adenosine - solution for injection - 3mg/1ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - adenosine 3 mg/ml - solution for injection in pre-filled syringe - 3 mg/ml - adenosine 3 mg/ml - adenosine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - adenosine 3 mg/ml - solution for injection in pre-filled syringe - 3 mg/ml - adenosine 3 mg/ml - adenosine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

fresenius kabi sa-nv - adenosine 3 mg/ml - solution for injection in pre-filled syringe - 3 mg/ml - adenosine 3 mg/ml - adenosine

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

hikma farmacêutica s.a. - adenosine 3 mg/ml - solution for injection - 6 mg/2 ml - adenosine 3 mg/ml - adenosine

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - adenosine phosphate disodium (unii: t1wz11dsrn) (adenosine phosphate - unii:415shh325a), pantothenic acid (unii: 19f5hk2737) (pantothenic acid - unii:19f5hk2737), sus scrofa pineal gland (unii: 050qz2edk7) (sus scrofa pineal gland - unii:050qz2edk7), lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), ubidecarenone (unii: ej27x76m46) (ubidecarenone - unii:ej27x76m46), melatonin (unii: jl5dk93rcl) (melatonin - unii:jl5dk93rcl), pyrrole (unii: 86s1zd6l2c) (pyrrole - unii:86s1zd6l2c), tryptophan (unii: 8duh1n11bx) (tryptophan - unii:8duh1n11bx), arsenic trioxide (unii: s7v92p67ho) (arsenic cation (3+) - unii:c96613f5av), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), matricaria chamomilla whole (unii: g0r4ubi2zz) (matricaria chamomilla whole - unii:g0r4ubi2zz), arabica coffee bean (unii: 3sw678mx72) (arabica coffee bean - unii:3sw678mx72), mercuric chloride (unii: 53gh7mzt1r) (mercuric cation - unii:ed30fj8y42), passiflora incarnata flowering top (unii: clf5yfs11o) (passiflora incarnata flowering top - unii:clf5yfs11o), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), zinc valerate dihydrate (unii: mn0rx54eqa) (valeric acid - unii:gzk92pjm7b), shigella dysenteriae (unii: 1ep6r5562j) (shigella dysenteriae - unii:1ep6r5562j), salmonella enterica subsp. enterica serovar enteritidis (unii: y3v16d4pv4) (salmonella enterica subsp. enterica serovar enteritidis - unii:y3v16d4pv4) - adenosine phosphate disodium 8 [hp_x] in 1 ml - adenosinum triphosphoricum dinatrum – difficulty sleeping, arsenicum album - tiredness, avena sativa - fatigue, chamomilla – difficulty sleeping, coffea cruda - tiredness, dysentery bacillus - fatigue, gaertner bacillus (bach) - tiredness, l-tryptophan – difficulty sleeping, melatonin - tiredness, mercurius corrosivus - fatigue, pantothenic acid - fatigue, passiflora incarnata – difficulty sleeping, pineal gland (suis) - fatigue, pyrrole - fatigue, sarcolacticum acidum - tiredness, silicea - fatigue, ubidecarenonum - tiredness, zincum valerianicum - tiredness • for the temporary relief of the symptoms including: • difficulty sleeping  • tiredness • fatigue these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

teva parenteral medicines, inc. - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine 3 mg in 1 ml - adenosine injection is indicated as an adjunct to thallium-201 myocardial perfusion scintigraphy in patients unable to exercise adequately. adenosine is contraindicated in patients with: - second- or third-degree av block (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker) [see warnings and precautions (5.2)] - known or suspected bronchoconstrictive or bronchospastic lung disease (e.g., asthma) [see warnings and precautions (5.3)] - known hypersensitivity to adenosine [see warnings and precautions (5.7)] animal reproduction studies have not been conducted with adenosine; nor have studies been performed in pregnant women. because it is not known whether adenosine can cause fetal harm when administered to pregnant women, adenosine should be used during pregnancy only if clearly needed. it is not known whether adenosine is excreted

United States - English - NLM (National Library of Medicine)

a-s medication solutions - adenosine (unii: k72t3fs567) (adenosine - unii:k72t3fs567) - adenosine injection is indicated for the following. conversion to sinus rhythm of paroxysmal supraventricular tachycardia (psvt), including that associated with accessory bypass tracts (wolff-parkinson-white syndrome). when clinically advisable, appropriate vagal maneuvers (e.g., valsalva maneuver), should be attempted prior to adenosine administration. it is important to be sure the adenosine solution actually reaches the systemic circulation (see dosage and administration ). adenosine does not convert atrial flutter, atrial fibrillation, or ventricular tachycardia to normal sinus rhythm. in the presence of atrial flutter or atrial fibrillation, a transient modest slowing of ventricular response may occur immediately following adenosine administration. adenosine injection is contraindicated in: - second- or third-degree a-v block (except in patients with a functioning artificial pacemaker). - sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning art